Here miRNA101 suppresses expression of the ICOS (a costimilatory molecule on T cells), which is defective in sanroque model of lupus, leading to stimulation of autoreactive B cells and a lupus-like illness [18]. The gene discussed is ICOS; the disease is systemic lupus erythematosus.